TC BioPharm (Holdings) plc ADR had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $138.00 on 11/27/23, while the lowest price during the same period was $0.63 on 11/15/24.
52-week price history of TCBP Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. TC BioPharm (Holdings) plc ADR’s current trading price is -99.52% away from its 52-week high, while its distance from the 52-week low is 4.90%. The stock’s price range for this period has remained between $0.63 and $138.00. The Healthcare sector company’s shares managed to surpass a trading volume of around 27.53 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.74 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
TC BioPharm (Holdings) plc ADR (TCBP) has experienced a quarterly decline of -83.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 0.21M and boasts a workforce of 41 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.2893, with a change in price of -7.2780. Similarly, TC BioPharm (Holdings) plc ADR recorded 765,031 in trading volume during the last 100 days, posting a change of -91.66%.
TCBP Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TCBP stands at 1.60. Similarly, the long-term debt-to-equity ratio is also 1.32.
TCBP Stock Stochastic Average
As of today, the raw stochastic average of TC BioPharm (Holdings) plc ADR over the past 50 days is 1.36%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 2.33%. Additionally, the Stochastic %K and %D values for the company were 1.60% and 1.54%, respectively, over the past 20 days.
TCBP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -97.91%. However, over the past six months, we’ve seen a stronger performance of -94.14%. The price of TCBP leaped by -87.07% over the last 30 days. And in the last five days, it has fallen by -41.93%.
